Yesterday’s Science Meets Today’s Crisis: Phage Therapy and MRSA

Tong SY, Davis JS, Eichenberger E, et al. Staphylococcus aureus infections: epidemiology, pathophysiology, clinical manifestations, and management. Clin Microbiol Rev. 2015;28(3):603–61.

Article  PubMed  PubMed Central  Google Scholar 

Wang WY, Lee SY, Chiueh TS, et al. Molecular and phenotypic characteristics of methicillin-resistant and vancomycin-intermediate Staphylococcus aureus isolates from patients with septic arthritis. J Clin Microbiol. 2009;47(11):3617–23.

Article  PubMed  PubMed Central  Google Scholar 

Chang RYK, Nang SC, Chan HK, et al. Novel antimicrobial agents for combating antibiotic-resistant bacteria. Adv Drug Deliv Rev. 2022;187:114378.

Article  PubMed  Google Scholar 

Plumet L, Ahmad-Mansour N, Dunyach-Remy C, et al. Bacteriophage therapy for Staphylococcus aureus infections: a review of animal models, treatments, and clinical trials. Front Cell Infect Microbiol. 2022;12:907314.

Article  PubMed  PubMed Central  Google Scholar 

Atshan SS, Hamat RA, Aljaberi MA, et al. Phage therapy as an alternative treatment modality for resistant Staphylococcus aureus infections. Antibiotics. 2023. https://doi.org/10.3390/antibiotics12020286.

Article  PubMed  PubMed Central  Google Scholar 

Jiang JH, Bhuiyan MS, Shen HH, et al. Antibiotic resistance and host immune evasion in Staphylococcus aureus mediated by a metabolic adaptation. Proc Natl Acad Sci USA. 2019;116(9):3722–7.

Article  PubMed  PubMed Central  Google Scholar 

Gómez Casanova N, Siller Ruiz M, Muñoz Bellido JL. Mechanisms of resistance to daptomycin in Staphylococcus aureus. Rev Esp Quimioter. 2017;30(6):391–6.

PubMed  Google Scholar 

Miller WR, Bayer AS, Arias CA. Mechanism of action and resistance to daptomycin in Staphylococcus aureus and enterococci. Cold Spring Harb Perspect Med. 2016. https://doi.org/10.1101/cshperspect.a026997.

Article  PubMed  PubMed Central  Google Scholar 

Lakhundi S, Zhang K. Methicillin-resistant Staphylococcus aureus: molecular characterization, evolution, and epidemiology. Clin Microbiol Rev. 2018. https://doi.org/10.1128/CMR.00020-18.

Article  PubMed  PubMed Central  Google Scholar 

McGuinness WA, Malachowa N, DeLeo FR. Vancomycin resistance in Staphylococcus aureus. Yale J Biol Med. 2017;90(2):269–81.

PubMed  PubMed Central  Google Scholar 

Monteiro AS, Pinto BL, Monteiro JM, et al. Phylogenetic and molecular profile of Staphylococcus aureus isolated from bloodstream infections in Northeast Brazil. Microorganisms. 2019;7(7):210.

Article  PubMed  PubMed Central  Google Scholar 

Álvarez A, Fernández L, Gutiérrez D, et al. Methicillin-resistant Staphylococcus aureus in hospitals: latest trends and treatments based on bacteriophages. J Clin Microbiol. 2019. https://doi.org/10.1128/JCM.01006-19.

Article  PubMed  PubMed Central  Google Scholar 

Lee AS, de Lencastre H, Garau J, et al. Methicillin-resistant Staphylococcus aureus. Nat Rev Dis Primers. 2018;4:18033.

Article  PubMed  Google Scholar 

Hamdy RF, Dona D, Jacobs MB, et al. Risk factors for complications in children with Staphylococcus aureus bacteremia. J Pediatr. 2019;208:214–e2202.

Article  PubMed  Google Scholar 

Craft KM, Nguyen JM, Berg LJ, et al. Methicillin-resistant Staphylococcus aureus (MRSA): antibiotic-resistance and the biofilm phenotype. Medchemcomm. 2019;10(8):1231–41.

Article  PubMed  PubMed Central  Google Scholar 

Ceccarelli F, Perricone C, Olivieri G, et al. Staphylococcus aureus nasal carriage and autoimmune diseases: from pathogenic mechanisms to disease susceptibility and phenotype. Int J Mol Sci. 2019. https://doi.org/10.3390/ijms20225624.

Article  PubMed  PubMed Central  Google Scholar 

Oduor JMO, Kadija E, Nyachieo A, et al. Bioprospecting Staphylococcus phages with therapeutic and bio-control potential. Viruses. 2020. https://doi.org/10.3390/v12020133.

Article  PubMed  PubMed Central  Google Scholar 

Cobb LH, Park J, Swanson EA, et al. CRISPR-Cas9 modified bacteriophage for treatment of Staphylococcus aureus induced osteomyelitis and soft tissue infection. PLoS ONE. 2019;14(11):e0220421.

Article  PubMed  PubMed Central  Google Scholar 

Feiner R, Argov T, Rabinovich L, et al. A new perspective on lysogeny: prophages as active regulatory switches of bacteria. Nat Rev Microbiol. 2015;13(10):641–50.

Article  PubMed  Google Scholar 

Criscuolo E, Spadini S, Lamanna J, et al. Bacteriophages and their immunological applications against infectious threats. J Immunol Res. 2017;2017:3780697.

Article  PubMed  PubMed Central  Google Scholar 

Du Toit A. Viral infection: the language of phages. Nat Rev Microbiol. 2017;15(3):134–5.

Article  PubMed  Google Scholar 

Yang H, Ma Y, Wang Y, et al. Transcription regulation mechanisms of bacteriophages: recent advances and future prospects. Bioengineered. 2014;5(5):300–4.

Article  PubMed  PubMed Central  Google Scholar 

Cui L, Watanabe S, Miyanaga K, et al. A comprehensive review on phage therapy and phage-based drug development. Antibiotics. 2024. https://doi.org/10.3390/antibiotics13090870.

Article  PubMed  PubMed Central  Google Scholar 

Liu K, Wang C, Zhou X, et al. Bacteriophage therapy for drug-resistant Staphylococcus aureus infections. Front Cell Infect Microbiol. 2024;14:1336821.

Article  PubMed  PubMed Central  Google Scholar 

Park JY, Moon BY, Park JW, et al. Genetic engineering of a temperate phage-based delivery system for CRISPR/Cas9 antimicrobials against Staphylococcus aureus. Sci Rep. 2017;7:44929.

Article  PubMed  PubMed Central  Google Scholar 

Becker SC, Foster-Frey J, Donovan DM. The phage K lytic enzyme LysK and lysostaphin act synergistically to kill MRSA. FEMS Microbiol Lett. 2008;287(2):185–91.

Article  PubMed  Google Scholar 

Kim NH, Park WB, Cho JE, et al. Effects of phage endolysin SAL200 combined with antibiotics on Staphylococcus aureus infection. Antimicrob Agents Chemother. 2018. https://doi.org/10.1128/AAC.00731-18.

Article  PubMed  PubMed Central  Google Scholar 

Chhibber S, Kaur T, Sandeep K. Co-therapy using lytic bacteriophage and linezolid: effective treatment in eliminating methicillin resistant Staphylococcus aureus (MRSA) from diabetic foot infections. PLoS ONE. 2013;8(2):e56022.

Article  PubMed  PubMed Central  Google Scholar 

Shimamori Y, Pramono AK, Kitao T, et al. Isolation and characterization of a novel phage SaGU1 that infects Staphylococcus aureus clinical isolates from patients with atopic dermatitis. Curr Microbiol. 2021;78(4):1267–76.

Article  PubMed  PubMed Central  Google Scholar 

Głowacka-Rutkowska A, Gozdek A, Empel J, et al. The ability of lytic Staphylococcal podovirus vB_SauP_phiAGO1.3 to coexist in equilibrium with its host facilitates the selection of host mutants of attenuated virulence but does not preclude the phage antistaphylococcal activity in a nematode infection model. Front Microbiol. 2018;9:3227.

Article  PubMed  Google Scholar 

Al-Ishaq RK, Skariah S, Büsselberg D. Bacteriophage treatment: critical evaluation of its application on world health organization priority pathogens. Viruses. 2020. https://doi.org/10.3390/v13010051.

Article  PubMed  PubMed Central  Google Scholar 

Alves DR, Gaudion A, Bean JE, et al. Combined use of bacteriophage K and a novel bacteriophage to reduce Staphylococcus aureus biofilm formation. Appl Environ Microbiol. 2014;80(21):6694–703.

Article  PubMed 

Comments (0)

No login
gif